Overview
Archer-Daniels-Midland Company (ADM), based in the United States, is a leading entity in the agricultural processing and food ingredients industry. The company operates on a global scale, focusing on procuring, transporting, and processing agricultural commodities. ADM's core endeavors include the transformation of oilseeds, corn, wheat, and other agricultural commodities into products for food, animal feed, industrial, and energy uses. A significant component of its operations involves utilizing its vast logistical network to optimize the distribution of goods worldwide. Key projects have recently aimed at expanding their capabilities in alternative proteins and sustainable materials, underlining ADM’s commitment to innovation while addressing responsibly sourced and environmentally conscious production methods. This strategic alignment positions ADM to capitalize on emerging market trends and maintain its industry leadership.
Basic Stats
The share price of Archer-Daniels-Midland Company as of September 5, 2025 is $62.95 / share. This is a decrease of -1.15% from the prior week. The market cap (or net worth) of Archer-Daniels-Midland Company as of September 5, 2025 is $30,216.00 MM.
The Factor Analysis chart (below right) shows a view of Archer-Daniels-Midland Company from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 30,216.00 MM |
| EV | 39,410.00 MM |
| Shares Out. | 480.00 MM |
| Earnings Date | |
| EPS (TTM) | 2.29 |
| Dividend Yield | 3.24 % |
| Ex-Dividend Date | 2025-08-20 |
| Borrow Rate | 0.39 |
| Short Shares Avail. | 5.60 MM |
| Short Interest | 8.17 MM |
| Short Float | 1.72 % |
| Days to Cover | 3.54 days |
| Risk Free Rate | 4.22 % |
| Price Change (1 yr) | 4.79 % |
| Volatility (1 yr) | 0.28 |
| Beta | 0.23 |
| Sharpe Ratio (1 yr) | 0.02 |
| Sortino Ratio (1 yr) | 0.03 |
| PE Ratio | 27.49 |
| Price/Book | 1.33 |
| Price/TBV | 1.96 |
| Book/Market | 0.75 |
| EBIT/EV | 0.04 |
| EBIT(3yr avg)/EV | 0.08 |
| ROA | 0.03 |
| ROE | 0.05 |
| ROIC | 0.03 |
| CROIC | 0.05 |
| OCROIC | 0.16 |
| Implied Volatility | 25.64 % |
| Put/Call OI Ratio | 0.58 |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Archer-Daniels-Midland Company is $58.98. The forecasts range from a low of $53.96 to a high of $73.50. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Archer-Daniels-Midland Company. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2022-12-14 | UBS | Buy | Initiate | |
| 2022-10-26 | Baird | Outperform | Maintains | |
| 2022-10-24 | B of A Securities | Neutral | Maintains | |
| 2022-08-12 | Wolfe Research | Outperform | Initiate | |
| 2022-07-27 | Baird | Outperform | Maintains | |
| 2022-05-02 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-04-27 | Credit Suisse | Neutral | Maintains | |
| 2022-04-22 | Barclays | Overweight | Maintains | |
| 2022-04-19 | B of A Securities | Buy | Neutral | Downgrade |
| 2022-03-16 | Goldman Sachs | Buy | Maintains | |
| 2022-01-11 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-12-13 | Barclays | Overweight | Maintains | |
| 2021-10-12 | Stephens & Co. | Overweight | Equal-Weight | Downgrade |
| 2021-07-21 | Jefferies | Hold | Initiate | |
| 2021-05-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-04-28 | Credit Suisse | Neutral | Maintains | |
| 2021-04-21 | B of A Securities | Buy | Initiate | |
| 2021-01-11 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2020-12-14 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-11-02 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-11-02 | Credit Suisse | Underperform | Neutral | Upgrade |
| 2020-10-19 | JP Morgan | Neutral | Overweight | Upgrade |
| 2020-08-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-07-28 | Seaport Global | Buy | Initiate | |
| 2020-07-27 | Credit Suisse | Neutral | Underperform | Downgrade |
| 2020-06-30 | Stifel | Buy | Maintains | |
| 2020-05-05 | Credit Suisse | Neutral | Maintains | |
| 2020-05-01 | Stifel | Buy | Maintains | |
| 2020-04-01 | Stifel | Buy | Maintains | |
| 2020-03-30 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-03-02 | Monness Crespi Hardt | Sell | Neutral | Upgrade |
| 2020-01-09 | Monness Crespi Hardt | Neutral | Sell | Downgrade |
| 2019-11-06 | Argus Research | Buy | Maintains | |
| 2019-10-17 | Credit Suisse | Neutral | Maintains | |
| 2019-10-08 | Stephens & Co. | Overweight | Initiate | |
| 2019-07-19 | Buckingham Research | Buy | Maintains | |
| 2019-06-26 | Stifel | Buy | Maintains | |
| 2019-04-30 | Stifel Nicolaus | Buy | Buy | Maintains |
| 2019-04-29 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2019-02-08 | Stifel Nicolaus | Hold | Buy | Upgrade |
| 2018-11-08 | Argus | Hold | Buy | Upgrade |
| 2018-08-03 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-08-01 | Buckingham | Buy | Buy | Maintains |
| 2018-08-01 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2018-07-09 | JP Morgan | Underweight | Neutral | Upgrade |
| 2018-05-02 | Monness Crespi Hardt | Sell | Neutral | Upgrade |
| 2018-05-02 | Citigroup | Buy | Buy | Maintains |
| 2018-04-09 | Buckingham | Buy | Buy | Maintains |
| 2018-04-06 | Credit Suisse | Neutral | Neutral | Maintains |
| 2018-03-12 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2018-03-06 | Citigroup | Neutral | Buy | Upgrade |
| 2018-02-28 | Buckingham | Neutral | Buy | Upgrade |
| 2018-02-07 | Stephens & Co. | Equal-Weight | Overweight | Upgrade |
| 2018-02-07 | Baird | Outperform | Outperform | Maintains |
| 2017-11-01 | BMO Capital | Market Perform | Maintains | |
| 2017-09-28 | Citigroup | Buy | Neutral | Downgrade |
| 2017-09-12 | Baird | Outperform | Initiate | |
| 2017-08-31 | Credit Suisse | Neutral | Maintains | |
| 2017-07-12 | Citigroup | Buy | Maintains | |
| 2017-06-01 | Argus | Buy | Hold | Downgrade |
| 2017-01-06 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2016-12-14 | PiperJaffray | Neutral | Initiate | |
| 2016-11-11 | JP Morgan | Neutral | Underweight | Downgrade |
| 2016-08-29 | Macquarie | Outperform | Maintains | |
| 2016-08-04 | Argus | Hold | Buy | Upgrade |
| 2016-07-12 | BB&T Capital | Hold | Initiate | |
| 2016-05-26 | Citigroup | Neutral | Buy | Upgrade |
| 2016-05-03 | Credit Suisse | Neutral | Maintains | |
| 2016-05-03 | Citigroup | Neutral | Maintains | |
| 2016-04-28 | Standpoint Research | Buy | Hold | Downgrade |
| 2016-04-22 | JP Morgan | Underweight | Neutral | Upgrade |
| 2016-03-07 | Bank of America | Buy | Neutral | Downgrade |
| 2016-02-12 | Argus | Buy | Hold | Downgrade |
| 2016-02-03 | BMO Capital | Market Perform | Maintains | |
| 2016-01-07 | Standpoint Research | Hold | Buy | Upgrade |
| 2015-11-04 | Buckingham Research | Neutral | Maintains | |
| 2015-10-19 | Buckingham Research | Neutral | Initiate | |
| 2015-07-29 | Citigroup | Buy | Neutral | Downgrade |
| 2015-07-07 | Vertical Research | Hold | Initiate | |
| 2015-04-02 | Citigroup | Buy | Maintains | |
| 2015-01-20 | JP Morgan | Neutral | Underweight | Downgrade |
| 2015-01-15 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2015-01-08 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2014-12-16 | Citigroup | Buy | Maintains | |
| 2014-10-28 | JP Morgan | Neutral | Maintains | |
| 2014-10-14 | Citigroup | Buy | Maintains | |
| 2014-08-06 | Citigroup | Buy | Maintains | |
| 2014-07-18 | JP Morgan | Neutral | Maintains | |
| 2014-07-09 | Citigroup | Buy | Maintains | |
| 2014-07-07 | Miller Tabak | Hold | Buy | Upgrade |
| 2014-04-30 | Stephens & Co. | Equal-Weight | Overweight | Upgrade |
| 2014-04-04 | Citigroup | Buy | Maintains | |
| 2014-03-10 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2014-02-05 | Scotiabank | Sector Perform | Sector Outperform | Upgrade |
| 2014-02-05 | Citigroup | Neutral | Buy | Upgrade |
| 2014-01-24 | Citigroup | Sell | Maintains | |
| 2013-12-24 | Stifel Nicolaus | Hold | Initiate | |
| 2013-12-23 | Stifel Nicolaus | Hold | Initiate | |
| 2013-12-17 | Macquarie | Outperform | Initiate | |
| 2013-10-31 | Argus | Hold | Buy | Upgrade |
| 2013-10-21 | Bank of America | Underperform | Buy | Upgrade |
| 2013-07-19 | JP Morgan | Underweight | Neutral | Upgrade |
| 2013-04-26 | Stephens & Co. | Overweight | Upgrade | |
| 2013-02-26 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2013-02-13 | Standpoint | Buy | Hold | Downgrade |
| 2013-01-07 | JP Morgan | Underweight | Initiate | |
| 2013-01-02 | Miller Tabak | Neutral | Buy | Upgrade |
| 2012-11-29 | Stephens & Co. | Initiate | ||
| 2012-11-20 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2012-10-17 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2012-08-15 | Standpoint Research | Hold | Buy | Upgrade |
| 2012-08-01 | Topeka | Hold | Maintains | |
| 2012-07-12 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2012-07-09 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2012-07-02 | Citigroup | Buy | Neutral | Downgrade |
| 2012-05-02 | Deutsche Bank | Hold | Maintains | |
| 2012-05-02 | Credit Suisse | Outperform | Maintains | |
| 2023-04-12 | JP Morgan | Neutral | Maintains | |
| 2023-04-13 | BMO Capital | Outperform | Reiterate | |
| 2023-04-14 | BMO Capital | Outperform | Reiterate | |
| 2023-04-13 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-04-26 | Baird | Outperform | Maintains | |
| 2023-04-26 | Barclays | Overweight | Maintains | |
| 2023-06-01 | Barclays | Overweight | Overweight | Maintains |
| 2023-04-27 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-10-19 | JP Morgan | Neutral | Neutral | Maintains |
| 2023-12-18 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2023-06-22 | Roth MKM | Buy | Initiate | |
| 2023-10-25 | Stephens & Co. | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-25 | JP Morgan | Neutral | Neutral | Maintains |
| 2023-07-17 | Morgan Stanley | Equal-Weight | Equal-Weight | Reiterate |
| 2023-12-20 | UBS | Buy | Buy | Maintains |
| 2023-08-01 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-08-01 | Argus Research | Buy | Buy | Maintains |
| 2023-07-31 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-02-01 | Citigroup | Neutral | Initiate | |
| 2023-10-30 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-03-13 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2024-03-13 | Jefferies | Hold | Hold | Maintains |
| 2024-01-23 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2024-01-22 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2024-01-22 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2024-01-22 | Baird | Outperform | Neutral | Downgrade |
| 2024-01-22 | Roth MKM | Buy | Neutral | Downgrade |
| 2024-01-22 | Barclays | Overweight | Underweight | Downgrade |
| 2024-01-22 | Stifel | Buy | Hold | Downgrade |
| 2024-01-26 | UBS | Buy | Neutral | Downgrade |
| 2024-03-14 | B of A Securities | Neutral | Neutral | Maintains |
| 2024-04-03 | Citigroup | Neutral | Neutral | Maintains |
| 2024-07-15 | Citigroup | Neutral | Neutral | Maintains |
| 2025-04-15 | Citigroup | Neutral | Neutral | Maintains |
| 2025-08-12 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-11-12 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-02-05 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2025-02-11 | B of A Securities | Underperform | Underperform | Maintains |
| 2024-12-04 | Barclays | Underweight | Underweight | Maintains |
| 2025-02-11 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-04-15 | B of A Securities | Underperform | Neutral | Upgrade |
| 2024-07-31 | JP Morgan | Neutral | Neutral | Maintains |
| 2025-02-24 | Barclays | Underweight | Underweight | Maintains |
| 2024-12-04 | Citigroup | Neutral | Neutral | Maintains |
| 2024-12-04 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2024-09-09 | UBS | Neutral | Neutral | Maintains |
| 2025-01-14 | B of A Securities | Neutral | Underperform | Downgrade |
| 2025-01-21 | Barclays | Underweight | Underweight | Maintains |
| 2025-07-02 | Barclays | Underweight | Underweight | Maintains |
| 2025-05-19 | UBS | Neutral | Buy | Upgrade |
| 2025-08-06 | Barclays | Underweight | Equal-Weight | Upgrade |
| 2025-05-08 | B of A Securities | Neutral | Underperform | Downgrade |
| 2025-08-11 | UBS | Buy | Buy | Maintains |
